Clinical Trials Logo

Filter by:
NCT ID: NCT04103255 Completed - Parkinson Disease Clinical Trials

High Frequency and Intensive Prevention Program

Start date: July 10, 2020
Phase: N/A
Study type: Interventional

The treatment of PD has made considerable advances in recent years with respect to drug therapies, as well as many new physiotherapy and drug-based methods, and there have also been great improvements in therapy thanks to deep brain stimulation. Cognitive rehabilitation has shown to be effective in PD (Abbruzzese et al., 2016), however, there has yet to be a major breakthrough in the treatment and prevention of PDD (Parkinson's Disease Dementia ). This is where the high frequency and intensive prevention described here comes into play.

NCT ID: NCT04102488 Completed - Hand Hygiene Clinical Trials

Simplifying the World Health Organization (WHO) Protocol for Hand Hygiene: Three Steps and 15 Seconds

SIHAG II
Start date: September 15, 2019
Phase: N/A
Study type: Interventional

This study is to investigate that non-inferiority in terms of reduction of bacterial counts will be retained when combining the simpler three-step technique for the use of hand rub with a shorter application time of 15 seconds.

NCT ID: NCT04097054 Completed - Clinical trials for Surgical Procedures, Operative

The 3P Trial: Preoperative Planning and Preparation of Complex and Rare Procedures in GI Surgery

Start date: November 15, 2022
Phase: N/A
Study type: Interventional

The aim of the present study is to develop, implement a planning tool for rare and complex visceral surgical procedures. With the successful implementation of the planning tool the study will contribute to the improvement of intraoperative processes and their outcome in low volume surgery and offer an alternative to continued centralization of surgical care especially in case of geographical or disease specific premises.

NCT ID: NCT04096248 Completed - Clinical trials for Stroke, Cardiovascular

CT (Computerized Tomography) for Late EndovasculAr Reperfusion

CLEAR
Start date: February 15, 2020
Phase:
Study type: Observational

The objective of this multicenter, retrospective, cross-sectional, chart review study is to compare outcomes (disability, complications and mortality) of patients with large vessel occlusion stroke presenting at late time window selected by either Non-Contrast CT (NCCT) only, advanced imaging with CTP (Computed Tomography Perfusion), MRI (Magnetic Resonance Imaging), or medical management. Boston Medical Center (BMC) will serve as the main data coordinating site. Fifteen additional sites will seek local IRB approval or ethics approval. The aggregated de-identified data will be analyzed comparing types of interventions and outcomes by type of imaging or medical management.

NCT ID: NCT04096131 Completed - Clinical trials for Diabetic Macular Edema

Influence of Cataract Surgery on Early DME The DICAT-II Study

DICAT-II
Start date: January 28, 2020
Phase:
Study type: Observational

To determine if cataract surgery may have an impact on the natural history of early DME (E-DME)

NCT ID: NCT04095559 Completed - Clinical trials for Atrial Fibrillation (AF)

Characterization of Left Atrial Substrate by Comparison of Bipolar Voltage Maps With Standard Focal 4.5 mm Tip Electrode, 1 mm Ring Electrode, and Microelectrode Catheters Using InTEllaMap Orion and IntellaNav MIFI O

CHAZESubstrate
Start date: December 5, 2019
Phase:
Study type: Observational

This study is to investigate the correlation and to obtain the coefficient of correlation between the global and local bipolar signals (voltage maps) of the LA in sinus rhythm using a focal 4.5 mm irrigated-tip ablation catheter (in combination with microelectrodes), a ring-electrode circular mapping catheter and a microelectrode multipolar catheter in combination with the Rhythmia system.

NCT ID: NCT04095273 Completed - Clinical trials for Advanced Solid Tumors

Study to Test How Well Patients With Advanced Solid Tumors Respond to Treatment With the Elimusertib in Combination With Pembrolizumab, to Find the Optimal Dose for Patients, How the Drug is Tolerated and the Way the Body Absorbs, Distributes and Discharges the Drug

Start date: September 30, 2019
Phase: Phase 1
Study type: Interventional

The purpose of the study is to test how well patients with advanced solid tumors respond to treatment with elimusertib (BAY1895344) in combination with pembrolizumab. In addition researchers want to find for patients the optimal dose of elimusertib in combination with pembrolizumab, how the drug is tolerated and the way the body absorbs, distributes and discharges the drug. The study medication, elimusertib, works by blocking a substance (ATR Kinase) which is produced by the body and is important for the growth of tumor cells. Pembrolizumab is an immunologic checkpoint blocker that promotes an immune response against the tumor.

NCT ID: NCT04094272 Completed - Chronic Hepatitis c Clinical Trials

Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus Infection

Start date: July 1, 2017
Phase:
Study type: Observational

The purpose of this study is the evaluation of PAH in patients, who are treated with DAA medication for HCV infection.

NCT ID: NCT04086654 Completed - Clinical trials for Post Traumatic Stress Disorder (PTSD)

Psychometric Properties of the International Trauma Interview (ITI) for ICD-11 PTSD and CPTSD

Start date: March 2, 2020
Phase: N/A
Study type: Interventional

The aim of the project is to evaluate the psychometric properties (e.g. validity, reliability) of the International Trauma Interview (ITI) - German version. The ITI is a structured clinical interview that corresponds to the ICD-11 criteria for diagnosing both posttraumatic stress disorder (PTSD) and complex posttraumatic stress disorder (CPTSD). Eligible participants from psychiatric inpatient and outpatient facilities in Switzerland who have provided informed will complete various self-report measures about trauma-related mental health complaints. In addition, the ITI will be conducted by a trained clinician. Lastly, information from the medical chart will be further used for scientific purpose. The overall assessment will take approximately 1-2 hours to complete.

NCT ID: NCT04085094 Completed - Clinical trials for Chronic Renal Failure

Gender Differences in Renal Functioning and Disease

GenderBOLD
Start date: May 30, 2017
Phase:
Study type: Observational

The purpose of the GenderBOLD study is to shed light on the mechanisms responsible for women's lower susceptibility to developing and progressing chronic renal disease, using modern imaging techniques, and applying different diets. The investigators postulate that oxygenation and renal perfusion are better conserved and change less in women than in men in different dietary situations (high salt-low salt), possibly because they are able to store excess salt in their skin and muscles. The investigators postulate that these differences are independent of their menstrual cycle. Finally, the investigators will analyze the renal functional reserve and changes in renal perfusion through an oral protein load and after sublingual nitroglycerin to assess whether potential différences exist between genders.